# NuvOx Expanded Access

> **NCT07748299** · — · AVAILABLE · sponsor: **NuvOx LLC**

## Conditions studied

- Glioblastoma
- Respiratory Distress Syndrom
- Ischemic Stroke
- Hypoxic Conditions

## Interventions

- **DRUG:** NanO₂

## Key facts

- **NCT ID:** NCT07748299
- **Lead sponsor:** NuvOx LLC
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** EXPANDED_ACCESS
- **Status:** AVAILABLE
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2026-08-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07748299

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07748299, "NuvOx Expanded Access". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07748299. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*